
I nearly died from my peanut allergy but now I eat them every day - here's how I cured myself
Chris Brookes-Smith could never have an enjoyable experience when eating out or abroad as he was plagued with fear that he could die if even the smallest trace of peanut crept into his food.
Ten years ago he suffered his worst allergic reaction after ordering a curry from his local Indian restaurant.
He was rushed to hospital when after one bite he developed spots on his lips and began vomiting.
Soon afterwards his throat closed up, hives formed all over his body and his face became swollen. 'I thought I was going to die,' he told the BBC.
The hives were so panful it felt 'like boiling water had been poured over me,' he added.
But now the cybersecurity specialist eats them every day with his breakfast after he participated in a clinical trial that changed his life.
The study at Guy's and St Thomas' NHS Foundation Trust and King's College London recruited 21 adults between 18 and 40 with a clinical diagnosis of the allergy to test if they could be desensitised, also known as oral immunotherapy.
It works by consuming microscopic amounts of peanuts and gradually increasing the dosage to build up immunity.
Chris was given small amounts of peanut powder to eat at home mixed with yoghurt. Patients are started with the equivalent of 0.5 per cent to one per cent of a whole peanut.
His dosage increased gradually and once he could tolerate 50-100mg of peanut protein he was switched to eating whole peanuts, peanut butter or peanut products.
Once participants achieved a daily dose of 1g they remained on this for at least four weeks before undergoing another food challenge.
This involved being given increasing doses of either peanut or placebo on separate days to test their tolerance. Participants then continued daily dosing for at least three months.
By the end of the nine-month study, which was funded by the National Institute for Health and Care Research, 14 of the patients were able to eat the equivalent of five peanuts without reacting—including Mr Brookes-Smith.
Anxious about willingly ingesting peanuts, the 28-year-old said his heart was going 'a million miles an hour' during the study.
But a team of doctors and nurses were on standby, with drugs such as adrenaline at the ready in case of a reaction.
'You've got 100 eyes on you, nothing is going to happen,' he said.
After successfully completing the trial, he told the BBC: 'I'm no longer afraid of dying.'
About one in every 200 adults in the UK—0.5 per cent—has a nut allergy. Life-threatening reactions called anaphylaxis occur when the immune system mistakenly overreacts, affecting a patient's ability to breathe.
However building tolerance is known to help calm and prevent this extreme reaction.
The trial, published in the journal Allergy, shows adults with serious allergies can increase the amount of peanut they can tolerate by 100 times.
Participants for whom the strategy works should eat four peanuts every morning to keep the allergy at bay, as recommended by doctors.
Chief Investigator Professor Stephen Till, Professor of Allergy at King's College London, said: 'Constant fear of life-threatening reactions place a huge burden on people with peanut allergy.
'The only way to manage a peanut allergy is strict avoidance and treatment of allergic reactions, including with adrenaline.
'Although peanut immunotherapy is known to be effective in children, this trial provides preliminary evidence that adults can also be desensitised and that this improves quality of life.'
But he said larger studies were needed to confirm findings.
Lead author, Hannah Hunter a specialist Allergy Dietitian from Guy's and St Thomas' NHS Foundation Trust said: 'Living with peanut allergy is a huge burden due to the need for constant vigilance and the risk of accidental exposures.
'Everyday situations such as eating in restaurants and social events are anxiety provoking and our patients tell us that the condition also affects travel choices and career options.
'We found that quality of life significantly improved after oral immunotherapy and fear of food also decreased. Many participants who completed the trial told us that the treatment had been life-changing and they were no longer living in fear.'
Public Health Minister, Ashley Dalton said: 'This groundbreaking research offers hope to thousands living with peanut allergies. For too long, people have navigated daily life in fear of accidental exposure that could be life-threatening.
'I'm proud the UK is leading this vital work through NIHR funding. These results show how we're transforming lives through science, potentially changing care standards for adults with peanut allergies worldwide.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


BBC News
3 hours ago
- BBC News
How eight seconds of scratchy audio from a VHS tape gave a mum back her voice
"After such a long time, I couldn't really remember my voice," Sarah Ezekiel tells BBC Access All. "When I first heard it again, I felt like crying. It's a kind of miracle."The onset of motor neurone disease (MND) left Sarah without a voice and the use of her hands at the age of 34. It was within months of her becoming a mum for the second they were growing up, her children Aviva and Eric only ever heard her speak through a machine with an emotionless robotic voice. But 25 years on, artificial intelligence (AI) has recreated their mum's real voice from just eight seconds of audio on a scratchy VHS tape. Sarah speaks to the BBC with eye-gaze technology - which uses a camera to track her eyes as she looks at letters on a screen in front of her. The sound of her younger voice rings out. The "miracle" Sarah describes began when Bristol-based assistive technology company, Smartbox, asked her for an hour's worth of audio to recreate her and her now-adult children hunted for something suitable - but Sarah had lost her voice in 2000, before smart phones were in wide-use and before social media captured moments. Eventually, an old VHS tape of Aviva as a baby was found, shot on a family camcorder in the 1990s. But the picture was wobbly and the sound distorted. The people in shot mumbled and were drowned out by a blaring audible, eight seconds of Sarah's voice could just about be heard. Sarah was a vivacious Londoner who had worked as a personal assistant in publishing when life took a with a toddler, the family was expecting a second baby. But Sarah didn't feel right. Her speech had been slowing and she felt a weakness in her left she was diagnosed with MND, sometimes referred to as ALS (amyotrophic lateral sclerosis). The degenerative condition causes muscle weakness and, of the 1,000 people diagnosed in the UK each year, the NHS says most will lose the ability to speak. MND affects men more, and can be life-shortening, but it varies from person to person and some people live long lives."I was in denial, thinking I'd be fine," says Sarah, but "after Eric was born, I deteriorated rapidly".Within months, Sarah lost the use of her hands, then "all intelligible speech". Her marriage ended soon after."I was very depressed and terrified of disability and death," she says. With two tiny children to care for, Sarah had to rely on 24-hour care."It was difficult to watch strangers care for my kids, but I'm grateful," says Sarah, sitting with Aviva and to move or communicate easily, Sarah battled with isolation. She says the first five years were spent watching bad TV, looking on as her children 25, says his only memories are of "mum being paralysed", while Aviva, 28, recalls the moment she realised her mum was different."I just have this memory of asking her to prepare some strawberries, and she wasn't able to cut them. She had to ask someone." Five years after her diagnosis, communication finally opened-up for Sarah, with the advent of eye-gaze technology. It meant she could build words and sentences with eye-movements - and speak, albeit with a synthetic voice, like the physicist Stephen Hawking. The technology enabled her to become a volunteer for the MND Association and a patron of the charity Lifelites, which seeks to give children and families tech so they can communicate. And she returned to her passion, painting, using eye-gaze technology to create original artworks."I was so happy, even though it was painstaking and tiring," she says. In Bristol, despite having asked for an hour's worth of audio, Simon Poole from Smartbox says his heart sank when he received only eight seconds from a VHS tape."I thought there's no way we're going to be able to create a voice using audio that bad," he says. But he played around with it nonetheless, looping it through the latest technology from international AI-voice company called ElevenLabs. The company had announced it wanted to provide free voice-cloning to one million people at risk of losing their speech, through conditions including MND, cancer or stroke, and cloning had worked for rugby player Rob Burrow. Eventually, Simon managed to set Sarah's voice apart from the sound of the blaring TV using ElevenLabs Voice Isolator. But the result was thin, devoid of intonation or personality, and it had an American lilt. So he turned to another app where, using thousands of voices, AI had been trained to fill in gaps left by the isolator and to predict where a voice, like Sarah's, might go with its Simon ended up with several audio phrases he was happy with - and sent them to recalls how she told him that she had almost cried upon first hearing her new, old voice. And that one of Sarah's old friends, someone who knew what she used to sound like, was "impressed by how realistic it was".But how would Aviva and Eric react when they heard it? "It was amazing," says Aviva. "I'm still coming to terms with it. Hearing it now in everyday life, it still surprises me."Sarah's new voice has also made the family closer, as Sarah can now express emotions and convey when she is happy, sad or angry. It has "made such a difference," says Eric."We can feel who she is as a person," Aviva says. "Mum isn't just a disabled person in the corner with a robot that doesn't relate to her." Voices created by AI are a big improvement on older, computerised ones - or from choosing from libraries of recorded voices - says Dr Susan Oman, a specialist in data, AI and society at Sheffield University. "It's about you as an individual, and your connection with who you are," she says. "If that [the voice] doesn't feel like you, then you don't feel like you."The preservation of accents is also "really important" at a time when technology could homogenise them, she says."It betrays your class. It betrays your origin. All over the world people are trying to reclaim accents and dialects that have been lost."Sarah jokes that she sometimes misses her old, synthetic voice. "I was very posh and people didn't know I was [really a] cockney with a slight lisp." But she is happy to have regained her old voice, she says. "I'm glad to be back. It's better than being a robot."


Times
13 hours ago
- Times
Mounjaro UK price rise will trigger obesity relapse, say experts
The upcoming Mounjaro price hike could cause people to pile weight back on and 'cycle in and out of obesity', experts have warned. The weight-loss jab, which is bought privately by 1.5 million people in the UK, will more than double in price next month — forcing patients off the drug if they can no longer afford it. Its manufacturer, Eli Lilly, is increasing the list price for the maximum 15mg dose from £122 to £330 for a monthly pen, while the 5mg dose is rising from £92 to £180. Pharmacies have warned that patients are in 'immense distress', with demand soaring as they stock up on Mounjaro before the price increase takes effect on September 1. Professor Tim Spector, a nutrition expert at King's College London, warned that the sudden increase in price had exposed the flaws of relying on weight-loss jabs to lose weight. He said: 'The price rise of the GLP-1 drugs comes at a tricky time for the million-plus Britons that have started taking the drugs. Any losses in weight they will have achieved will be reversed in just a few weeks, as their appetite kicks back in. 'People are being prompted to use these private networks of GLP-1 drugs without any real supervision, and, crucially, without any nutritional support.' Spector, co-founder of the Zoe nutrition app, said that people who were taking weight-loss jabs should instead have been 're-educated about food and good eating habits long term'. He added: 'It's a huge wasted opportunity that's going to get worse as the price for the consumer goes up, and therefore people are unlikely to stay on this long term. We're just going to be back to good old short-term diets, which will cycle people in and out of obesity.' The price hike is taking place after President Trump demanded that pharmaceutical firms lower prices for American patients and stop other countries 'freeloading' off US firms. Pharmacies said they were experiencing record demand and were helping people to switch from Mounjaro to Wegovy, a similar GLP-1 drug known as Ozempic when used for diabetes, as it is cheaper, although not thought to be as effective. • Jon Yeomans: Mounjaro is a taste of the battle to come over drug prices James O'Loan, the chief executive of the online pharmacy Chemist4U, said: 'The distressing news that prices are set to rise by up to 170 per cent with just two weeks' notice, in response to another aggressive initiative from Trump, is very troubling. It's caused immense distress to hundreds of thousands of UK patients on a weight loss journey, who worry all their hard-earned progress could be snatched away from them.' Asda Online Doctor said: 'Following the announcement of steep price increases by the manufacturer Eli Lilly starting in September, we have seen an instant 350 per cent increase in demand. We are making all efforts to enable our existing patients to continue treatment and are actively prioritising them. 'However, this will be a difficult situation for many of our patients with affordability being a key aspect in the access and/or continuation of these services. Therefore we deeply regret this decision from Eli Lilly to increase prices, which will affect many patients. We remain committed to providing an excellent service to our patients at a fair price.' • Mounjaro transformed me — but it had a huge effect on my family's life Dr Leyla Hannbeck, chief executive of the Independent Pharmacies Association, representing thousands of community pharmacies, said: 'Our members up and down the country have been dealing with worried patients, many of whom are enquiring about stocking up before the price increase hits. 'There is a very real danger that the higher prices will see patients desperate for cheaper products turn to the, often unregulated, online market.' Sandeep Dhami, a superintendent pharmacist at MW Phillips Chemists in the West Midlands, added: 'Patients on their weight-loss journeys are coming into pharmacies like mine angry and upset at the news of the price hike. Those on the highest doses, who will face the highest price hike are particularly concerned.'


Daily Mirror
15 hours ago
- Daily Mirror
BBC Gardeners' World star had 'to-do list' as she opens up on battle with devastating illness
Gardeners' World star Rachel de Thame was diagnosed with breast cancer in 2018, and said that it had a knock-on effect to her life and left her feeling "shaken" Gardeners' World presenter Rachel de Thame has opened up about her "desperate" to-do list following her breast cancer diagnosis in 2018, revealing how the news sent "shockwaves" through her life. Penning her thoughts for The Times at the time, Rachel shared: "While one is grateful to have options, treatment is no walk in the park. Strangely, though, I've also found that there are compensations. Top of the list is a renewed, almost desperate desire to get on with some of the things that for too long have lingered on a mental to-do list." The beloved BBC personality reflected on the impact of her health scare, stating: "When you've felt rocked to your foundations, the only sensible thing is to get on with living." With a newfound outlook, Rachel admitted she's now viewing life through a different lens, with ambitions to transform her garden into a sanctuary for herself and others. She elaborated on her aspirations: "On a more immediate and personal level, I'm focusing on next spring and how I want my garden to look and, above all, make me feel." Fortunately, Rachel's condition was detected early, prompting her to take time off from Gardeners' World as she embarked on her treatment journey. Speaking to the BBC during this period, she conveyed optimism: "I'm doing well and coming towards the end of it. It's caught early so that's all very positive, so on the whole it's better not to be working too much just now," reports the Express. Thankfully, she made a complete recovery and has since extolled the virtues of gardening for its role in her physical and mental well-being during that tough time. At the Chelsea Flower Show, Rachel expressed: "I know there's a big message this year at Chelsea about the importance of gardening for your general health and mental health, if you're going through some chronic illness, whatever it is, it's vital to go out and be in a garden." In one of the most recent episodes of Gardeners' World, fans were left in tears after expert Steve opened up about his terminal diagnosis. He shared: "Very recently, I had been diagnosed with a terminal cancer, and I don't know how long I might live. It could be two months or two years, possibly. "I didn't feel down as a result of it, I just saw it as another challenge, I'm going to have to sort something out for this. "And actually, I have had a big, creative burst, I think, as a result of that positive attitude, and I am getting there. I am finding ways in which Pippa and our son, between them, will be able to manage this whole process once I've gone."